Respirerx Pharmaceuticals Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 289K |
---|---|---|---|---|---|
Net income 2021 | -3M | Net income 2022 | -2M | EV / Sales 2021 | - |
Net Debt 2021 | 2.08M | Net Debt 2022 | 2.71M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.29
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.37% |
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-10-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Director/Board Member | - | 23-03-21 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
1st Jan change | Capi. | |
---|---|---|
+15.79% | 121B | |
+18.43% | 112B | |
+4.43% | 22.57B | |
-18.18% | 20.82B | |
-13.84% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.10% | 13.17B | |
+27.14% | 11.11B |